Features & Compatibility
This research blend combines CJC-1295, a synthetic analogue of growth hormone-releasing hormone (GHRH), with Ipamorelin, a selective growth hormone secretagogue receptor agonist.
The two compounds act through distinct but complementary signaling mechanisms associated with growth hormone release. This makes the blend useful for controlled laboratory studies involving GHRH signaling, ghrelin-receptor activity, growth-hormone pulsatility and GH/IGF-1 pathway regulation.
Variants:
10mg10vials | 20mg10vials
For laboratory research use only. Not intended for human consumption or therapeutic use.
Customer Reviews
Related Products
BPC+TB500
This research blend combines BPC-157 and TB-500, two peptides investigated in laboratory models involving cellular repair and tissue-response mechanisms. BPC-157
Eloralintide
Eloralintide, formerly known as LY3841136, is an investigational, long-acting and selective amylin receptor agonist. It is designed to mimic amylin,
NAD+
NAD+ (Nicotinamide Adenine Dinucleotide) is an essential coenzyme naturally present in living cells. It plays a central role in cellular
Semax
Semax is a synthetic heptapeptide composed of an ACTH (4–7) fragment combined with the Pro-Gly-Pro (PGP) sequence. It is studied
TB500(Thymosin B4 Acetate)
TB-500 is a synthetic research peptide related to Thymosin Beta-4, a naturally occurring actin-binding peptide involved in cellular organization and
Tirzepatide
Tirzepatide is a modified peptide that acts as a dual agonist of the GIP and GLP-1 receptors. Its dual-receptor profile

Reviews
There are no reviews yet.